Targeted Interventions for Weight-Concerned Smokers
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
Weight gain after quitting smoking is an important barrier to treatment for many smokers.
This study will test a drug called naltrexone with weight-concerned smokers to investigate
whether or not this drug both improves smoking cessation quit rates and minimizes post quit
weight gain.
Phase:
Phase 2
Details
Lead Sponsor:
Yale University
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)